Tyra biosciences to present at oppenheimer's 34th annual healthcare life sciences conference

Carlsbad, calif. , feb. 7, 2024 /prnewswire/ -- tyra biosciences, inc. (nasdaq: tyra), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in fibroblast growth factor receptor (fgfr) biology, today announced that todd harris, ceo of tyra, will present at oppenheimer's 34th annual healthcare life sciences conference on tuesday, february 13, 2024, at 2pm et.
TYRA Ratings Summary
TYRA Quant Ranking